Glucose, glycolysis and lymphocyte responses

Molecular Immunology

Volumn 68, Issue 2, 2015, Pages 513-519

  Donnelly, Raymond P ^a   Finlay, David K ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

B cell; c Myc; Galactose; GAPDH; Glucose; Glycolysis; Granzyme B; HIF1 ; IFN ; Lymphocyte; Metabolism; mTORC1; Natural Killer cell; Oxidative phosphorylation; Review; T cell

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; GLYCOLYTIC ENZYME; MESSENGER RNA;

ARTICLE; B LYMPHOCYTE; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL METABOLISM; ENERGY; GLYCOLYSIS; LYMPHOCYTE; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; GLUCOSE; GLYCOLYSIS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES;

EID: 84949084914     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.07.034     Document Type: Article

References (50)

1. Araki K., et al. mTOR regulates memory CD8 T-cell differentiation. Nature 2009, 460(7251):108-112.
2. Blair D., Dufort F.J., Chiles T.C. Protein kinase Cbeta is critical for the metabolic switch to glycolysis following B-cell antigen receptor engagement. Biochem J. 2012, 448(1):165-169.
3. Caro-Maldonado A., et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 2014, 192(8):3626-3636.
4. Castello A., et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 2012, 149(6):1393-1406.
5. Cham C.M., Gajewski T.F. Glucose availability regulates IFN-gamma production and p70S6 kinase activation in CD8+ effector T cells. J. Immunol. 2005, 174(8):4670-4677.
6. Cham C.M., et al. Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells. Eur. J. Immunol. 2008, 38(9):2438-2450.
7. Chang C.H., et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 2013, 153(6):1239-1251.
8. Chou C., et al. c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells. Nat. Immunol. 2014, 15(9):884-893.
9. De B.P., et al. Specific interaction in vitro and in vivo of glyceraldehyde-3-phosphate dehydrogenase and LA protein with cis-acting RNAs of human parainfluenza virus type 3. J. Biol. Chem. 1996, 271(40):24728-24735.
10. Delgoffe G.M., et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 2009, 30(6):832-844.
11. Delgoffe G.M., et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 2011, 12(4):295-303.
12. Donnelly R.P., et al. mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function. J. Immunol. 2014, 193(9):4477-4484.
13. Dose M., et al. Intrathymic proliferation wave essential for Valpha14+ natural killer T cell development depends on c-Myc. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(21):8641-8646.
14. Doughty C.A., et al. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 2006, 107(11):4458-4465.
15. Dufort F.J., et al. Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism. J. Immunol. 2007, 179(8):4953-4957.
16. Finlay D.K., et al. Temporal differences in the dependency on phosphoinositide-dependent kinase 1 distinguish the development of invariant Valpha14 NKT cells and conventional T cells. J. Immunol. 2010, 185(10):5973-5982.
17. Finlay D.K., et al. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J. Exp. Med. 2012, 209(13):2441-2453.
18. Frey P.A. The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose. FASEB J. 1996, 10(4):461-470.
19. Gerriets V.A., Rathmell J.C. Metabolic pathways in T cell fate and function. Trends Immunol. 2012, 33(4):168-173.
20. Gubser P.M., et al. Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat. Immunol. 2013, 14(10):1064-1072.
21. Hentze M.W., Muckenthaler M.U., Andrews N.C. Balancing acts: molecular control of mammalian iron metabolism. Cell 2004, 117(3):285-297.
22. Hume D.A., et al. Aerobic glycolysis and lymphocyte transformation. Biochem. J. 1978, 174(3):703-709.
23. Macintyre A.N., et al. The glucose transporter Glut1 is selectively essential for CD4+ T cell activation and effector function. Cell Metab. 2014, 20(1):61-72.
24. Man K., et al. The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nat. Immunol. 2013, 14(11):1155-1165.
25. Marcais A., et al. The metabolic checkpoint kinase mTOR is essential for IL- signaling during the development and activation of NK cells. Nat. Immunol. 2014, 15(8):749-757.
26. Michalek R.D., et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4++ T cell subsets. J. Immunol. 2011, 186(6):3299-3303.
27. Mukhopadhyay R., et al. The GAIT system: a gatekeeper of inflammatory gene expression. Trends Biochem. Sci. 2009, 34(7):324-331.
28. Nagy E., Rigby W.F. Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold). J. Biol. Chem. 1995, 270(6):2755-2763.
29. Oestreich K.J., et al. Bcl-6 directly represses the gene program of the glycolysis pathway. Nat. Immunol. 2014, 15(10):957-964.
30. Pearce E.L., Pearce E.J. Metabolic pathways in immune cell activation and quiescence. Immunity 2013, 38(4):633-643.
31. Pearce E.L., et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009, 460(7251):103-107.
32. Pollizzi K.N., Powell J.D. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat. Rev. Immunol. 2014, 14(7):435-446.
33. Powell J.D., et al. Regulation of immune responses by mTOR. Annu. Rev. Immunol. 2011.
34. Rolf J., et al. AMPKalpha1: a glucose sensor that controls CD8 T-cell memory. Eur. J. Immunol. 2013, 43(4):889-896.
35. Salio M., et al. Essential role for autophagy during invariant NKT cell development. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(52):E5678-E5687.
36. Schlesinger M., Bekesi J.G. Inhibition of human natural killer activity by 2-deoxy--glucose and other sugars. J. Clin. Lab. Immunol. 1984, 15(1):19-26.
37. Schultz D.E., Hardin C.C., Lemon S.M. Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5'-nontranslated RNA of hepatitis A virus. J. Biol. Chem. 1996, 271(24):14134-14142.
38. Shi L.Z., et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 2011, 208(7):1367-1376.
39. Shin J., et al. Mechanistic target of rapamycin complex 1 is critical for invariant natural killer T-cell development and effector function. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(8):E776-E783.
40. Sinclair L.V., et al. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 2013, 14(5):500-508.
41. Sukumar M., et al. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J. Clin. Invest. 2013, 123(10):4479-4488.
42. van der Windt G.J., et al. CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(35):14336-14341.
43. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324(5930):1029-1033.
44. Wang T., Marquardt C., Foker J. Aerobic glycolysis during lymphocyte proliferation. Nature 1976, 261(5562):702-705.
45. Wang R., et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 2011, 35(6):871-882.
46. Warburg O., Gawehn K., Geissler A.W. [Metabolism of leukocytes]. Z Naturforsch B 1958, 13B(8):515-516.
47. Warburg O. On the origin of cancer cells. Science 1956, 123(3191):309-314.
48. Wei J., Yang K., Chi H. Cutting edge: Discrete functions of mTOR signaling in invariant NKT cell development and NKT17 fate decision. J. Immunol. 2014, 193(9):4297-4301.
49. Zang W.Q., et al. Identification of glyceraldehyde-3-phosphate dehydrogenase as a cellular protein that binds to the hepatitis B virus posttranscriptional regulatory element. Virology 1998, 248(1):46-52.
50. Zhang L., et al. Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function. J. Immunol. 2014, 193(4):1759-1765.